Diabetes Mellitus: all 11,089 studies
Page 106 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363948Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363844Phase 3
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusCompletedNCT00363519Phase 3
- The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes MellitusCompletedNCT00363233Phase 2/3
- Olmesartan Medoxomil and Diabetic NephropathyCompletedNCT00362960Phase 3
- Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 DiabetesCompletedNCT00362011Phase 2
- The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).CompletedNCT00361946
- Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With DiabetesTerminatedNCT00361907Phase 2/3
- Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin TreatmentCompletedNCT00361738Phase 2
- Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes MellitusCompletedNCT00361153Phase 2
- Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and NephropathyCompletedNCT00361023Not applicable
- Prevention of Severe Hypoglycemia in Type 1 DiabetesCompletedNCT00360984Phase 4
- CBT in Adolescents With Type 1 DiabetesCompletedNCT00360061Not applicable
- Improving Diabetes Care Collaboratively in the CommunityCompletedNCT00359996Not applicable
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCompletedNCT00359879Phase 3
- Noninvasive Skin Spectroscopy for Diabetes ScreeningCompletedNCT00358254
- Behavior Therapy for Families of Diabetic AdolescentsCompletedNCT00358059Phase 3
- Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction ClinicCompletedNCT00358033Phase 3
- Evaluate the Efficacy of Insulin Patients With Type 1 DiabetesCompletedNCT00356109Phase 3
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesCompletedNCT00355849Phase 3
- Testosterone Replacement in Diabetes With Vascular Disease (Version 2)CompletedNCT00355537Phase 4
- Insulin Analogue With Continuous Glucose Monitoring System (CGMS) MeasurementCompletedNCT00354939Phase 4
- In-patient Study With GSK716155 In Patients With Type 2 Diabetes MellitusCompletedNCT00354536Phase 2
- DARE: Diabetes in cArdiac REhabilitationCompletedNCT00354237Not applicable
- Bioavailability of Insulin Administered in DuodenumCompletedNCT00353990Phase 1/2
- Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusCompletedNCT00353691Phase 3
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on InsulinCompletedNCT00353587Phase 2/3
- Diabetes Mellitus and Vulvovaginal CandidiasisCompletedNCT00353561Phase 3
- Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00351884Phase 3
- A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 DiabetesCompletedNCT00351832Phase 3
- Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET ScanCompletedNCT00351650
- A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 DiabetesCompletedNCT00351585Phase 3
- A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 DiabetesCompletedNCT00351546Phase 3
- A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00351507Phase 3
- Carnitine Levels and Carnitine Supplementation in Type I DiabetesCompletedNCT00351234
- LANTUSTITR: Insulin Glargine in Type 2 Diabetes MellitusTerminatedNCT00349986Phase 4
- A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNCT00349427Phase 3
- Testosterone for Men With Insulin Treated Type 2 DiabetesCompletedNCT00349362Phase 4
- Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
- Jikei Optimal Insulin Therapy in Type 2 DiabetesStatus unknownNCT00348231Not applicable
- Exercise and Activity Guidance in Older Adults With DiabetesCompletedNCT00344240Not applicable
- Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00343980Phase 3
- Comparison of NovoFine® Needles (4 mm vs. 6 mm)CompletedNCT00343343Phase 2
- Family Investigation of Nephropathy and Diabetes (F.I.N.D.)Active, not recruitingNCT00342927
- Exercise Training in Older Diabetic WomenCompletedNCT00341614Phase 1
- Family Management of Childhood Diabetes StudyCompletedNCT00340938Phase 1
- Management of Type 1 Diabetes Among AdolescentsCompletedNCT00340639
- Lunch Time Insulin Injection by School Nurse for Poorly Controlled DiabetesCompletedNCT00340613Phase 4
- Diabetes Management Personal TrainerCompletedNCT00340093Phase 1
- Mapping Genes for Type 2 (Non-Insulin Dependent) Diabetes MellitusCompletedNCT00339885
- Predictive and Protective Factors in the Cause of Diabetes - A Study in TwinsCompletedNCT00339781
- Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.CompletedNCT00339703
- Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian CommunityCompletedNCT00339482
- Food Intake and Appetite in the Children of Mothers With DiabetesCompletedNCT00339313
- Multiple Grain in Type 2 DiabetesStatus unknownNCT00337337Phase 4
- The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 DiabetesCompletedNCT00337298Not applicable
- Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 DiabetesCompletedNCT00336674Phase 2
- A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot PainCompletedNCT00336349Not applicable
- A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus PatientsStatus unknownNCT00336310Phase 4
- Pilot Study of ONO-5129 in Patients With Type 2 Diabetes MellitusCompletedNCT00335712Phase 2
- Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 MutationsCompletedNCT00334711Not applicable
- Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)CompletedNCT00333853Not applicable
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneCompletedNCT00333723Phase 4
- Nutritional Intervention to Prevent DiabetesCompletedNCT00333554Not applicable
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00333151Phase 3
- Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and AsthmaTerminatedNCT00332826Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
- Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedNCT00331604Phase 3
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- Gene Expression Profiling in Type 1 DiabetesCompletedNCT00330954
- A Concordance Study Comparing Insulin Treatments in Patients With Type 2 DiabetesCompletedNCT00330473Phase 3
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior TreatmentCompletedNCT00330330Phase 2
- Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 DiabeticsTerminatedNCT00330200Phase 2
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinCompletedNCT00329225Phase 4
- Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In KoreaCompletedNCT00328965Phase 4
- Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes MellitusCompletedNCT00328536Phase 4
- Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney BiopsyStatus unknownNCT00328302Phase 4
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With SulfonylureaWithdrawnNCT00327626Phase 2
- Trial of Motivational Interviewing in Adolescents With DiabetesTerminatedNCT00326573Phase 1/2
- Patient Education in NorthTrondelag Hospital TrustCompletedNCT00326222Not applicable
- Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot StudyTerminatedNCT00325910Phase 3
- Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel)CompletedNCT00325624Phase 1
- The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes MellitusCompletedNCT00325559Not applicable
- Long-Term Safety Study of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00325429Phase 3
- Study of Human Insulin Inhalation Powder in Patients With Type 2 DiabetesCompletedNCT00325364Phase 3
- To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea MonotherapyCompletedNCT00325117Phase 3
- I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With DiabetesCompletedNCT00324792Not applicable
- Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet StudyCompletedNCT00324584Phase 3
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCompletedNCT00324363Phase 3
- Molecular Quantification of Insulin mRNACompletedNCT00324207
- Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of DiabetesCompletedNCT00322478Phase 2/3
- Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesTerminatedNCT00322257Phase 3
- LANCGMS - Lantus Continuous Glucose Monitoring SubcutaneousCompletedNCT00322075Phase 4
- Coronary CT Angiography in Asymptomatic Diabetes MellitusStatus unknownNCT00321542
- Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.CompletedNCT00321256Phase 1/2
- Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and MicroalbuminuriaActive, not recruitingNCT00320008Not applicable
- Efficacy and Safety of Nateglinide Treatment in Renal Transplant RecipientsCompletedNCT00319189Phase 4
- Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCompletedNCT00318786Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 DiabetesStatus unknownNCT00318032Not applicable